OTLK 250117 10.00C (OTLK250117C10000) Stock Options, News & Quotes

US OptionsDetailed Quotes

OTLK250117C10000

Watchlist

0.05
0.000.00%

15min DelayClose Jan 17 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Outlook Therapeutics Price Target Maintained With a $12.00/Share by Guggenheim
Dow JonesJan 17 09:26 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Outlook Therapeutics, Maintains $30 Price Target
BenzingaJan 17 07:31 ET
Outlook Therapeutics Analyst Ratings
BenzingaJan 17 07:29 ET · Ratings
Positive Outlook for Outlook Therapeutics Driven by Promising ONS-5010 Data and Strategic Market Positioning
TipRanksJan 17 06:16 ET
Sector Update: Health Care Stocks Rise Late Afternoon
MT NewswiresJan 16 15:54 ET
Outlook Therapeutics Shares Fall After Reporting Trial Results for ONS-5010 in Wet AMD
MT NewswiresJan 16 12:44 ET

Comments

Jaguar8

Jan 16 09:02

NEWS

$Outlook Therapeutics (OTLK.US)$
Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
Thursday, 16th January at 6:00 am
ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks
BLA resubmission on track for calendar Q1 2025
Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in gross proceeds
ISELIN, N.J., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Outlook Th...

carlton griffiths

Jan 13 17:49

Share Your Profit/Loss

carlton griffiths

Jan 13 14:27

Share Your Profit/Loss

carlton griffiths

Jan 2 12:12

$Outlook Therapeutics (OTLK.US)$ good news

carlton griffiths

Dec 30, 2024 17:41

Share Your Profit/Loss